Loading...
Amrubicin is effective against small cell carcinoma of the prostate as a second‐line chemotherapeutic agent: A case report
INTRODUCTION: Small cell carcinoma of the prostate has a poor prognosis. Furthermore, treatments for small cell carcinoma of the prostate have not been established. We report a case where amrubicin was effective for second‐line chemotherapy. CASE PRESENTATION: A 50‐year‐old man complaining of painfu...
Na minha lista:
| Udgivet i: | IJU Case Rep |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley and Sons Inc.
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7292199/ https://ncbi.nlm.nih.gov/pubmed/32743393 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/iju5.12058 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|